Abbott EPI drug for cystic fibrosis gets FDA approval
CREON delayed-release capsules (pancreatic enzyme medicine) are indicated for the improving food digestion in people who cannot digest food properly because they have EPI. Abbott Global Pharmaceutical Development
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.